Health · Series A
Morrow Bio
Sector
Health
Stage
Series A
Headquarters
Boston
Partnered
2022, Series A
Designing new proteins with machine learning, turning a decade of lab work into weeks.
Most medicines are proteins, and finding a new one has always meant years of trial and error. Morrow's models design candidate proteins on a computer and its automated lab tests thousands of them a week.
We led the Series A to scale the lab and the partnerships around it. Morrow now works with three of the world's largest drug makers on programmes in immunology and rare disease.
Backing founders with conviction, from the first cheque to the last round. Tell us what you’re building.
© 2026 Kinetic Partners. A fictional firm created for the Kinetic Partners template. Nothing here is an offer or investment advice.
Photography is illustrative.
